Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France.
Univ Angers, Univ Brest, IRF, SFR ICAT, F-49000 Angers, France.
Curr Opin Plant Biol. 2022 Jun;67:102200. doi: 10.1016/j.pbi.2022.102200. Epub 2022 Mar 24.
Plants represent a huge reservoir of natural products. A broad series of these compounds now find application for human health. In this respect, the monoterpene indole alkaloids (MIAs), particularly from Madagascar periwinkle, are a prominent example of plant specialized metabolites with an important therapeutic potential. However, the supply of MIA drugs has always been a challenge since the low-yield accumulation in planta. This mainly results from the complex architecture of the MIA biosynthetic pathway that involves several organs, tissue types and subcellular organelles. Here, we describe the most recent advances towards the elucidation of this pathway route as well as its spatial organization in planta. Besides allowing a better understanding of the MIA biosynthetic flux in the whole plant, such knowledge will also probably pave the way for the development of metabolic engineering strategies to sustain the MIA supply.
植物是天然产物的巨大宝库。现在,这些化合物的广泛系列被应用于人类健康。在这方面,单萜吲哚生物碱(MIAs),特别是来自马达加斯加长春花的 MIAs,是具有重要治疗潜力的植物特化代谢物的一个突出例子。然而,由于在植物体内产量低,MIA 药物的供应一直是一个挑战。这主要是由于 MIA 生物合成途径的复杂结构造成的,该途径涉及多个器官、组织类型和亚细胞细胞器。在这里,我们描述了在阐明该途径路线及其在植物体内的空间组织方面的最新进展。除了能够更好地理解整个植物中 MIA 生物合成通量之外,这种知识还可能为开发代谢工程策略来维持 MIA 供应铺平道路。